For Health Care Providers (HCPs)
VeraCept Clinical Data
CAUTION: New Drug – Limited by Federal Law to Investigational Use
ContraMed is actively recruiting Phase 2 Clinical Study participants in a number of U.S. cities.
- Clinical Study Title:
- Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception
- ClinicalTrials.gov Identifier: